Research and Innovation
RCSI is purposefully committed to solving the greatest challenges of modern healthcare.
Our translational research enhances patient treatment, informs policy and clinical practice, and improves the quality of education of healthcare professionals.
Making a difference
RCSI research has found that venetoclax, a medication currently approved for leukaemia, has benefits for patients with multiple myeloma when used in combination with another drug.
New research by RCSI's Dr Alain Chan Kwo Chion has identified how a new medicine can help people living with the bleeding disorder von Willebrand disease.
Lockdowns imposed during the COVID-19 pandemic had an impact on the gut microbiome development of babies born during these periods according to new research.
Secondary-school aged adolescents in Ireland reported more mental health problems in 2021, including an increase in suicide attempts, compared to previous years, according to new findings.
Research
As an exclusively health sciences-focused educational and research institution, RCSI is uniquely placed to drive translational research which benefits patients and the community.
Explore our research
Innovation
We work with industry partners, licensees, RCSI spin-out companies and other key stakeholders across all healthcare sectors to bring our innovative medical research from bench to bedside.
Find out more
